…eduction in proliferation within a subset of colon tumours upon SU1644 treatment, a potential strategy to target metastasis in right-s…
cetuximab
This drug is selected. Its supporting articles are shown below.
Articles mentioning cetuximab
17 articles · page 2 of 2…roblastoma, and glioblastoma tumors, when given after a dose of 5-fluorouracil.2–4 5-FU provides myelo-depletion and releases cancer cell neoa…
…g immunosuppressive regimens comprising various combinations of sirolimus, everolimus, prednisone, cellcept, cyclosporine, tacrolimus, be…
…) or unknown (30.8%, 53.8%). The most common ICI agent used was pembrolizumab (92.3%), with 7 patients receiving ICI as a first-line systemic…
…, et al. KEYNOTE-689: phase 3 study of adjuvant and neoadjuvant pembrolizumab combined with standard of care (SOC) in patients with resectabl…